Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
HN Registry
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
1 other identifier
observational
5,028
3 countries
79
Brief Summary
The registry is a multi-center, prospective, observational study designed to collect data in patients with euvolemic and hypervolemic hyponatremia in the hospital setting in the USA and hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Europe; patients with hypovolemic hyponatremia will be excluded from the registry. The registry is observational in design, and the registry will collect data on patients with a serum sodium ≤130 mmol/L. Data from the patients' chart will be collected throughout the duration of the hospital, from admission to discharge, and the data will be entered into the case report form (CRF) or into an electronic data capture (EDC) system. These patients will be entered into the registry over the duration of 18 months at community, tertiary, and academic medical centers from diverse multiple regions of the USA and Europe. A patient's treatment will be determined by their caregiver and not by this protocol. Thus, the registry will provide a unique opportunity to evaluate how the patients are managed under real-world management conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2010
Typical duration for all trials
79 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 11, 2010
CompletedFirst Posted
Study publicly available on registry
November 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMay 15, 2015
May 1, 2015
2.8 years
November 11, 2010
May 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in serum sodium concentration from beginning of treatment period to the end of treatment period or discharge for a given hyponatremia treatment
Hospital Discharge
Duration of hospital stay from time of first presentation of hyponatremia (which will be taken as the time of first presentation of hyponatremia for the current admission) to discharge
Hospital Discharge
Time to initiation of hyponatremia treatment
Hospital Discharge
Secondary Outcomes (8)
Relative proportions of etiologies associated with hyponatremia
Hospital Discharge
Profile of investigations performed in diagnosing hyponatremia
Hospital Discharge
Therapies used in the management of hyponatremia
Hospital Discharge
Effectiveness of individual therapies in correcting hyponatremia and time taken to achieve the correction.
Hospital Discharge
Effectiveness of individual therapies in correcting hyponatremia and time taken to achieve the correction.
Hospital Discharge
- +3 more secondary outcomes
Study Arms (1)
Hyponatremia Patients
Euvolemic or hypervolemic hyponatremia with serum sodium ≤130 mmol/L
Eligibility Criteria
The prospective registry study population will consist of up to 1500 patients at approximately 150 sites from the USA who are hospitalized and identified as having hypervolemic or euvolemic hyponatremia with serum sodium ≤130 mmol/L. Also up to 1005 patients at approximately 67 sites from Europe (United Kingdom, Germany, France, Italy, Spain, Denmark, and Sweden)who are identified as having hyponatremia ≤130mmol/L secondary to SIADH. A similar distribution of patients with a serum sodium \<125 mmol/L and patients with a serum sodium between 125-130 mmol/L will be collected.
You may qualify if:
- Adults ≥18 years old who are hospitalized
- Euvolemic or hypervolemic hyponatremia with serum sodium ≤130mmol/L
- For euvolemic hyponatremia:
- Euvolemia is defined as: absence of clinical and historical evidence of extracellular fluid volume depletion or sequestration; and absence of edema and ascites; or
- Physician diagnosis of SIADH
- For hypervolemic hyponatremia (applies to USA sites only):
- Hypervolemia is defined as: excess extracellular fluid volume manifesting as dependent edema or ascites
- Patients may have one or more of the following underlying co-morbid conditions:
- Congestive heart failure
- Cirrhosis and/or liver failure
- Nephrotic syndrome
You may not qualify if:
- Patients with hypovolemic hyponatremia
- Use of investigational drug, biologic, or device during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Otsuka America Pharmaceuticallead
- Registrat-Mapicollaborator
Study Sites (79)
North America Research Institute
Azusa, California, United States
Chrishard Medical Group
Inglewood, California, United States
UCLA
Los Angeles, California, United States
Regional Cardiology Associates
Sacramento, California, United States
Portercare Adventist Health System
Denver, Colorado, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
Memorial Healthcare System
Hollywood, Florida, United States
Jacksonville Cardiovascular Center
Jacksonville, Florida, 32216, United States
Kidney & HTN Specialists of Miami
Miami, Florida, United States
Naples Community Hospital
Naples, Florida, United States
Florida Hospital
Orlando, Florida, United States
Coastal Nephrology Associates Research
Port Charlotte, Florida, United States
St. Joseph's Hospital of Atlanta
Atlanta, Georgia, United States
Joseph M Still Research Foundation, Inc
Augusta, Georgia, 30909, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Loyola University Medical Center
Maywood, Illinois, United States
Research Integrity, LLC
Owensboro, Kentucky, United States
Ochsner Multi-Organ Transplant Center
New Orleans, Louisiana, United States
Detroit Medical Center
Detroit, Michigan, United States
Detroit Receiving Hospital
Detroit, Michigan, United States
Central Michigan Community Hospital
Mount Pleasant, Michigan, United States
Providence Park Hospital
Novi, Michigan, United States
Northern Michigan Hospital
Petoskey, Michigan, United States
Covenant Heart Specialists
Saginaw, Michigan, United States
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Saint Louis University Hosptial
St Louis, Missouri, United States
Creighton University
Omaha, Nebraska, United States
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89106, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Hypertenstion and Renal Group
Livingston, New Jersey, United States
St Joseph's Regional Medical Center
Paterson, New Jersey, United States
Princeton Hypertension Nephrology Associates
Princeton Junction, New Jersey, United States
Tufts New England Medical Center
Boston, New York, United States
Buffalo General Hospital
Buffalo, New York, United States
The Jamaica Hospital Medical Center
Jamaica, New York, United States
Winthrop-University Hospital
Mineola, New York, United States
Beth Israel Medical Center-Petrie Division
New York, New York, United States
Center for Liver Disease and Transplantation
New York, New York, United States
Mount Sinai School of Medicine
New York, New York, United States
NYU
New York, New York, United States
Rochester General
Rochester, New York, United States
University of Rochester
Rochester, New York, United States
St Catherine of Siena Medical Center
Smithtown, New York, United States
Jack D. Weiler Hospital
The Bronx, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Duke University
Durham, North Carolina, United States
Piedmont Respiratory Research
Greensboro, North Carolina, United States
Mercy Hospital
Canton, Ohio, United States
University of Cinncinati
Cincinnati, Ohio, United States
Metrohealth Medical Center
Cleveland, Ohio, 44109, United States
Cleveland Clinic
Cleveland, Ohio, United States
Mercy Hospital Fairfield
Fairfield, Ohio, 45104, United States
Kettering Health Network
Kettering, Ohio, United States
Kidney Care Specialists
Kettering, Ohio, United States
St Elizabeth Health Center
Youngstown, Ohio, United States
NE Clinical Research Center
Bethlehem, Pennsylvania, United States
Delaware County Memorial Hospital
Drexel Hill, Pennsylvania, United States
Heart Specialists of Lancaster PC
Eprata, Pennsylvania, United States
Laurel Health System
Mansfield, Pennsylvania, United States
UPMC Center for Liver Disease
Pittsburgh, Pennsylvania, United States
SC Nephrology & Hypertension Ctr
Orangeburg, South Carolina, United States
Southeast Renal Research Institute
Chattanooga, Tennessee, United States
Saint Thomas Hospital
Nashville, Tennessee, United States
Baylor University Medical Center
Dallas, Texas, United States
Cardiopulmonary Research Science & Technology Institute
Dallas, Texas, United States
Baptist Hospital Downtown
San Antonio, Texas, 78205, United States
Renal Associates, PA
San Antonio, Texas, United States
Clinical Research and Consulting Centter
Fairfax, Virginia, United States
Sentara Norfolk General Hospital
Norfolk, Virginia, United States
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
CAMC Institute Inc.
Charleston, West Virginia, United States
Evangelische Lungenklinik
Berlin, Germany
Klinikum Chemnitz
Chemnitz, Germany
Universitätsklinik Köln
Cologne, Germany
Klinikum der Johann-Wolfgang-Goethe-Universität
Frankfurt, Germany
Birmingham Heartlands Hospital
Birmingham, United Kingdom
Royal Liverpool University Hospital
Liverpool, United Kingdom
Royal Victoria Infirmary
Newcastle, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2010
First Posted
November 15, 2010
Study Start
September 1, 2010
Primary Completion
June 1, 2013
Study Completion
August 1, 2013
Last Updated
May 15, 2015
Record last verified: 2015-05